Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Axomadol in Recreational Opiate Users
NCT03768024Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Jun 2007
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of axomadol in pain and acute pain (7 arms), sponsored by Grünenthal GmbH. Primary endpoints: Overall Drug Liking at 48 hours and Subjective Drug Value at 48 hours. Started Jun 2007; status: completed.
02
Drugs
axomadol
03
Conditions
painacute pain
Beyond the preview
Go deeper on NCT03768024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03768024.